CH396845A - Verfahren zur Verbesserung der physikalischen Eigenschaften von Koazervatmembranen - Google Patents

Verfahren zur Verbesserung der physikalischen Eigenschaften von Koazervatmembranen

Info

Publication number
CH396845A
CH396845A CH8206059A CH8206059A CH396845A CH 396845 A CH396845 A CH 396845A CH 8206059 A CH8206059 A CH 8206059A CH 8206059 A CH8206059 A CH 8206059A CH 396845 A CH396845 A CH 396845A
Authority
CH
Switzerland
Prior art keywords
coacervate
membranes
improving
physical properties
physical
Prior art date
Application number
CH8206059A
Other languages
English (en)
Inventor
Hugo Jensen Erik
Original Assignee
Ncr Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ncr Co filed Critical Ncr Co
Publication of CH396845A publication Critical patent/CH396845A/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N25/00—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
    • A01N25/26—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests in coated particulate form
    • A01N25/28—Microcapsules or nanocapsules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5089—Processes
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J13/00—Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
    • B01J13/02—Making microcapsules or microballoons
    • B01J13/06—Making microcapsules or microballoons by phase separation
    • B01J13/10—Complex coacervation, i.e. interaction of oppositely charged particles

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Wood Science & Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Agronomy & Crop Science (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Dentistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Environmental Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Colloid Chemistry (AREA)
CH8206059A 1958-12-22 1959-12-19 Verfahren zur Verbesserung der physikalischen Eigenschaften von Koazervatmembranen CH396845A (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US78193058A 1958-12-22 1958-12-22

Publications (1)

Publication Number Publication Date
CH396845A true CH396845A (de) 1965-08-15

Family

ID=25124414

Family Applications (1)

Application Number Title Priority Date Filing Date
CH8206059A CH396845A (de) 1958-12-22 1959-12-19 Verfahren zur Verbesserung der physikalischen Eigenschaften von Koazervatmembranen

Country Status (3)

Country Link
CH (1) CH396845A (de)
DE (1) DE1141263B (de)
GB (2) GB929406A (de)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3965033A (en) * 1970-07-27 1976-06-22 Fuji Photo Film Co., Ltd. Process for the production of oil-containing microcapsules
CA1044134A (en) * 1975-04-09 1978-12-12 Minnesota Mining And Manufacturing Company Microcapsule insecticide composition
FR2464093A1 (fr) * 1979-08-30 1981-03-06 Roussel Uclaf Procede de preparation de suspensions ou de poudres stables de microcapsules stables et d'une porosite variable et les produits ainsi obtenus
DE3016170A1 (de) * 1980-04-26 1981-10-29 Bayer Ag, 5090 Leverkusen Mikrokapseln mit definierter oeffnungstemperatur, verfahren zu deren herstellung sowie deren verwendung
US4808408A (en) * 1983-05-11 1989-02-28 Bend Research, Inc. Microcapsules prepared by coacervation
WO2001026627A1 (en) * 1999-10-14 2001-04-19 1170535 Ontario Inc. Liposome encapsulated silver salt compositions
FR2857592B1 (fr) * 2003-07-18 2006-02-24 Sod Conseils Rech Applic Nouveau procede de preparation de microparticules
EP1750683B1 (de) * 2004-04-23 2013-01-09 Amgen Inc. Formulierungen mit verzögerter freisetzung
US9822364B2 (en) 2008-03-11 2017-11-21 Yale University Compositions and methods for controlled delivery of inhibitory ribonucleic acids
WO2013123492A2 (en) 2012-02-17 2013-08-22 Massachusetts Institute Of Technology Glucose-responsive microgels for closed loop insulin delivery
US8962577B2 (en) 2012-03-16 2015-02-24 The Johns Hopkins University Controlled release formulations for the delivery of HIF-1 inhibitors
JP6138904B2 (ja) 2012-03-16 2017-05-31 ザ・ジョンズ・ホプキンス・ユニバーシティー 活性剤の送達のための非線状マルチブロックコポリマー薬物コンジュゲート
WO2014160404A1 (en) 2013-03-13 2014-10-02 The Regents Of The University Of California Improved oral drug devices and drug formulations
JP2017503860A (ja) 2014-01-10 2017-02-02 チャンバー ワークス，エルエルシー 皮膚への適用または刺青インクへの添加のための個別化物質およびその製造方法
WO2015138951A1 (en) 2014-03-14 2015-09-17 Chamber Works, Llc Articles of jewelry containing a personalizing additive such as dna and methods of making
EP3179985A1 (de) 2014-08-14 2017-06-21 Brown University Zusammensetzungen zur stabilisierung und ausgabe von proteinen
JP6847848B2 (ja) 2014-12-15 2021-03-24 ザ ジョーンズ ホプキンズ ユニバーシティＴｈｅ Ｊｏｈｎｓ Ｈｏｐｋｉｎｓ Ｕｎｉｖｅｒｓｉｔｙ スニチニブ製剤、及び緑内障の治療におけるその使用方法
US20180008718A1 (en) 2015-01-20 2018-01-11 The Johns Hopkins University Compositions for the sustained release of anti-glaucoma agents to control intraocular pressure
AR106018A1 (es) 2015-08-26 2017-12-06 Achillion Pharmaceuticals Inc Compuestos de arilo, heteroarilo y heterocíclicos para el tratamiento de trastornos médicos
WO2017035408A1 (en) 2015-08-26 2017-03-02 Achillion Pharmaceuticals, Inc. Compounds for treatment of immune and inflammatory disorders
US10864170B2 (en) 2015-09-04 2020-12-15 Yale University Polymeric bile acid nanocompositions targeting the pancreas and colon
HK1257499A1 (zh) 2015-11-12 2019-10-25 Graybug Vision, Inc. 用於治疗的聚集性微粒
JP2019508037A (ja) 2016-02-16 2019-03-28 イェール ユニバーシティーＹａｌｅ Ｕｎｉｖｅｒｓｉｔ 標的化遺伝子編集を増強するための組成物およびその使用方法
US20200308590A1 (en) 2016-02-16 2020-10-01 Yale University Compositions and methods for treatment of cystic fibrosis
WO2017151879A1 (en) 2016-03-02 2017-09-08 The Johns Hopkins University Compositions for sustained release of anti-glaucoma agents to control intraocular pressure
SG11201811491YA (en) 2016-06-27 2019-01-30 Achillion Pharmaceuticals Inc Quinazoline and indole compounds to treat medical disorders
KR20230109771A (ko) 2016-09-13 2023-07-20 노쓰 캐롤라이나 스테이트 유니버시티 혈소판 조성물 및 치료제의 전달 방법
WO2018187493A1 (en) 2017-04-04 2018-10-11 Yale University Compositions and methods for in utero delivery
AU2018265415A1 (en) 2017-05-10 2019-10-31 Graybug Vision, Inc. Extended release microparticles and suspensions thereof for medical therapy
US20210162013A1 (en) 2018-08-03 2021-06-03 Brown University Compositions and methods for improving the bioavailability of glp1 and analogues thereof
US20210189431A1 (en) 2018-08-10 2021-06-24 Yale University Compositions and methods for embryonic gene editing in vitro
EP4167958A1 (de) 2020-06-19 2023-04-26 Yale University Polymere gallensäureesternanopartikel mit einem immunmodulator zur induzierung antigenspezifischer toleranz
EP4251283A1 (de) 2020-11-27 2023-10-04 General Nanotherapeutics LLC Verfahren und zusammensetzung zur behandlung von immunvermittelten erkrankungen

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2800457A (en) * 1953-06-30 1957-07-23 Ncr Co Oil-containing microscopic capsules and method of making them

Also Published As

Publication number Publication date
DE1141263B (de) 1962-12-20
GB929406A (en) 1963-06-19
GB929405A (en) 1963-06-19

Similar Documents

Publication Publication Date Title
CH396845A (de) Verfahren zur Verbesserung der physikalischen Eigenschaften von Koazervatmembranen
CH395033A (de) Verfahren zur Verminderung der Durchlässigkeit von Überzügen
CH411921A (de) Verfahren zur Herstellung von Aminoacetonitrilen
CH388622A (de) Verfahren zur Herstellung von Mischpolymerisaten
CH374653A (de) Verfahren zur Cyclisierung von Pseudojononen
CH417965A (de) Verfahren zur Herstellung von Heteroblock-Copolymeren
CH409892A (de) Verfahren zur Herstellung von Peroxo-monosulfaten
CH397677A (de) Verfahren zur Herstellung von Aroylalkylpiperidinen
CH396846A (de) Verfahren zur Verminderung der Durchlässigkeit von Überzügen
CH396843A (de) Verfahren zur Verbesserung der physikalischen Eigenschaften von Koazervatmembranen
CH394758A (de) Verfahren zur Regenerierung von Chromatierungslösungen
CH393273A (de) Verfahren zur Verbesserung der physikalischen Eigenschaften von Koazervatmembranen
CH390234A (de) Verfahren zur Herstellung von Vinylthioäthylthiolphosph3r- bzw, -phosphonsäureestern
CH408015A (de) Verfahren zur Herstellung von 3-Nitro-azacyclo-alkanon-2-N-carbochloriden
CH387645A (de) Verfahren zur Herstellung von Rhodantriazinen
CH377358A (de) Verfahren zur Herstellung von Di-alkylenimiden
CH351108A (de) Verfahren zur Herstellung von Mischpolymerisaten
CH375362A (de) Verfahren zur Herstellung von 4-Chinazolonen
CH400993A (de) Verfahren zur Verbesserung der mechanischen Eigenschaften von cellulosehaltigem Textilgut
CH397672A (de) Verfahren zur Herstellung von Tetraorganodiphosphinen
CH417104A (de) Verfahren zur Herstellung von Eupolyoxymethylenen
CH358070A (de) Verfahren zur Anreichung von Isotopen
CH369133A (de) Verfahren zur Herstellung von substituierten Tetrahydro-oxazinen
CH378880A (de) Verfahren zur Herstellung von Reichsteins-Substanz-S
CH391723A (de) Verfahren zur Herstellung von 3-Aralkyl-2-tert.-amino-alkyl-indenen